Literature DB >> 1978615

Anesthesia for craniotomy: a double-blind comparison of alfentanil, fentanyl, and sufentanil.

R P From1, D S Warner, M M Todd, M D Sokoll.   

Abstract

Using a prospective, randomized, and double-blind study design, alfentanil (n = 15), fentanyl (n = 14), or sufentanil (n = 16), in combination with N2O, were administered to patients undergoing craniotomy for supratentorial tumor resection. Physicians were given two syringes, one of which was labeled as "load" for the initial loading dose and the other as "maintenance" for continuous infusion. The concentration of drug in each syringe was adjusted to permit administration on a milliliter per kilogram basis. The target loading doses for alfentanil, fentanyl, and sufentanil were 75, 10, and 1 microgram/kg, respectively, and initial infusion rates were 33.5, 2.0, and 0.3 microgram.kg-1.h-1, respectively. Additional supplementary boluses and changes in maintenance infusion rate were made according to predetermined guidelines. Isoflurane, in increasing 0.2% inspired increments, was used only when the maximum allowed opioid dose had been given (i.e., supplementary bolus doses equal to 75% of the calculated loading dose or supplementary bolus doses equal to 50% of the calculated loading dose combined with a 50% increase in the maintenance infusion rate). Opioid infusions were stopped at the time of bone flap replacement. Antihypertensive medications and naloxone were subsequently given at the discretion of the anesthesiologist. Group demographics were not different. Total volumes of drug were similar among groups indicating equipotent preparations. Administration of isoflurane, antihypertensive medications, and naloxone were not different among groups. Although decreases in blood pressure seen with induction were similar among groups, alfentanil-treated patients received ephedrine more frequently before intubation. Thirty minutes after entry into the postanesthesia recovery area, respiratory rate and pH were lowest in sufentanil-treated patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978615

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Intraoperative anesthetic management of patients undergoing glomus tumor resection using a low-dose isoflurane-fentanyl technique.

Authors:  W S Jellish; J Murdoch; J Leonetti
Journal:  Skull Base Surg       Date:  1994

3.  Efficacy of fentanyl and/or lidocaine on total antioxidants and total oxidants during craniotomy.

Authors:  Ayse Mizrak; Ibrahim Erkutlu; Mehmet Alptekin; Elzem Sen; Murat Geyik; Abdulvahab Gok; Unsal Oner
Journal:  Clin Med Res       Date:  2011-01-24

4.  Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequencies.

Authors:  Li Gong; Qian Qin; Lei Zhou; Wen Ouyang; Yanshuang Li; Yuhui Wu; Yunli Li
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

5.  The anaesthetic management of neurosurgical emergencies.

Authors:  R A Craen; A W Gelb
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

6.  Comparison of fentanyl, sufentanil and alfentanil during awake craniotomy for epilepsy.

Authors:  E Gignac; P H Manninen; A W Gelb
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

7.  Gender rather than choice of intermediate duration opioids affects emergence after craniotomy for large intracranial tumors.

Authors:  Anupa Deogaonkar; Mimi Khin; Samuel Samuel; Zeyd Y Ebrahim; Edward J Mascha; Armin Schubert
Journal:  Ochsner J       Date:  2011

Review 8.  Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy.

Authors:  Eugenia Ayrian; Alan David Kaye; Chelsia L Varner; Carolina Guerra; Nalini Vadivelu; Richard D Urman; Vladimir Zelman; Philip D Lumb; Giovanni Rosa; Federico Bilotta
Journal:  J Clin Med Res       Date:  2015-08-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.